{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:11:53Z","timestamp":1792800713956,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Northeastern University USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Justice"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Massachusetts passed legislation in 2018 to mandate provision of medications for opioid use disorder (MOUD) in select jails to address the high risk of opioid overdose after release. Since 2019, we have conducted a Type-1 hybrid effectiveness-implementation study of this program. We present findings on the perspectives and experiences of persons treated in these jails.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted qualitative analyses of semi-structured interviews that were conducted in 2022 with 38 adults released to the community who had been treated with MOUD while living in one of eight Massachusetts jails. The Exploration, Preparation, Implementation, and Sustainment (EPIS) framework informed development of the interview guide and analysis of qualitative data. Deductive and inductive strategies were used for coding and analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Participants were 41.5 years old; predominantly male; 84.2% white, 23.7% Hispanic\/Latino and 7.9% Black; and most continued taking MOUD. Thematic analysis focused on four code reports: Perception of Addiction\/MOUD, Barriers\/Facilitators, Impact of MOUD in Jails, and Stigma. Participants perceived that MOUD helped to prevent relapse. Prompt and consistent access to medication, and respectful treatment by healthcare and carceral staff were highlighted as facilitators. In contrast, some participants perceived that policy-centered rather than patient-centered treatment drove timing of medication initiation or response to medication changes. Insufficient staffing and the COVID-19 pandemic contributed to treatment delays. Overall, individuals incarcerated in jails that have expanded treatment eligibility to include earlier induction with MOUD generally felt more positive about their experience than individuals reporting delayed induction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Participants valued the ability of jail based MOUD programs to help clients achieve recovery from OUD. Their perceptions highlight the intrinsic value of MOUD programs that promote and support wellbeing through a person-centered approach to treatment. Participants stressed that MOUD programs should be patient-centered and guided by patients\u2019 symptoms and needs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40352-025-00319-7","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:30:28Z","timestamp":1745339428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient perspectives of jail based MOUD treatment: views of individuals who have returned to the community following incarceration"],"prefix":"10.1186","volume":"13","author":[{"given":"Claudia","family":"Santelices","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Rottapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Pivovarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"1","key":"319_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10488-010-0327-7","volume":"38","author":"GA Aarons","year":"2011","unstructured":"Aarons, G. A., Hurlburt, M., & Horwitz, S. M. (2011). Advancing a conceptual model of evidence-based practice implementation in public service sectors. Administration and Policy in Mental Health, 38(1), 4\u201323. https:\/\/doi.org\/10.1007\/s10488-010-0327-7","journal-title":"Administration and Policy in Mental Health"},{"key":"319_CR2","doi-asserted-by":"publisher","unstructured":"Atkins, J., Dopp, A. L., & Temaner, E. B. (2020). Combatting the stigma of addiction - The need for a comprehensive health system approach. NAM Perspect. ; 2020:https:\/\/doi.org\/10.31478\/202011d","DOI":"10.31478\/202011d"},{"key":"319_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1748-5908-8-4","volume":"8","author":"JK Benzer","year":"2013","unstructured":"Benzer, J. K., Beehler, S., Cramer, I. E., et al. (2013). Between and within-site variation in qualitative implementation research. Implementation Sci, 8, 4. https:\/\/doi.org\/10.1186\/1748-5908-8-4","journal-title":"Implementation Sci"},{"issue":"3","key":"319_CR4","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1097\/QAI.0000000000002216","volume":"82","author":"LK Beres","year":"2019","unstructured":"Beres, L. K., Simbeza, S., Holmes, C. B., Mwamba, C., Mukamba, N., Sharma, A., Munamunungu, V., Mwachande, M., Sikombe, K., Bolton Moore, C., Mody, A., Koyuncu, A., Christopoulos, K., Jere, L., Pry, J., Ehrenkranz, P. D., Budden, A., Geng, E., & Sikazwe, I. (2019). Human-centered design lessons for implementation science: Improving the implementation of a patient-centered care intervention. Journal of Acquired Immune Deficiency Syndromes, 82(3), S230\u2013S243. https:\/\/doi.org\/10.1097\/QAI.0000000000002216","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"319_CR5","doi-asserted-by":"publisher","unstructured":"Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007). Release from prison\u2013a high risk of death for former inmates. N Engl J Med. ;356(2):157\u201365. https:\/\/doi.org\/10.1056\/NEJMsa064115. Erratum in: N Engl J Med. 2007;356(5):536.","DOI":"10.1056\/NEJMsa064115"},{"key":"319_CR6","unstructured":"Center for Disease Control and Prevention. Understanding the epidemic. Centers for Disease Control and Prevention (2018). Retrieved from https:\/\/www.fraudfighters.net\/wp-content\/uploads\/2021\/03\/Understanding-the-Epidemic-_-Drug-Overdose-_-CDC-Injury-Center.pdf. Accessed [date]."},{"issue":"3","key":"319_CR10","doi-asserted-by":"publisher","first-page":"e236108","DOI":"10.1001\/jamanetworkopen.2023.6108","volume":"6","author":"G D\u2019Onofrio","year":"2023","unstructured":"D\u2019Onofrio, G., Hawk, K. F., Perrone, J., Walsh, S. L., Lofwall, M. R., Fiellin, D. A., & Herring, A. (2023). Incidence of precipitated withdrawal during a multisite emergency department-initiated buprenorphine clinical trial in the era of fentanyl. JAMA Netw Open, 6(3), e236108. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.6108","journal-title":"JAMA Netw Open"},{"key":"319_CR8","unstructured":"Data Brief: Opioid-Related Overdose Deaths among Massachusetts residents (2023). Retrieved from:https:\/\/www.mass.gov\/doc\/opioid-related-overdose-deaths-among-ma-residents-december-2023\/download. Accessed: January 11, 2024."},{"key":"319_CR9","unstructured":"Dedoose Version 9.0.107. (2021). Dedoose Version 9.0.107 cloud application for managing, analyzing, and presenting qualitative and mixed method research data. SocioCultural Research Consultants, LLC. https:\/\/www.dedoose.com"},{"key":"319_CR12","doi-asserted-by":"publisher","first-page":"108275","DOI":"10.1016\/j.jsat.2021.108275","volume":"128","author":"EA Evans","year":"2021","unstructured":"Evans, E. A., Stopka, T. J., Pivovarova, E., Murphy, S. M., Taxman, F. S., Ferguson, W. J., Bernson, D., Santelices, C., McCollister, K. E., Hoskinson, R. Jr, Lincoln, T., Friedmann, P. D., & MassJCOIN Research Group. (2021). Massachusetts justice community opioid innovation network (MassJCOIN). Journal of Substance Abuse Treatment, 128, 108275. https:\/\/doi.org\/10.1016\/j.jsat.2021.108275","journal-title":"Journal of Substance Abuse Treatment"},{"key":"319_CR11","doi-asserted-by":"publisher","first-page":"108746","DOI":"10.1016\/j.jsat.2022.108746","volume":"138","author":"EA Evans","year":"2022","unstructured":"Evans, E. A., Pivovarova, E., Stopka, T. J., Santelices, C., Ferguson, W. J., & Friedmann, P. D. (2022). Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail. Journal of Substance Abuse Treatment, 138, 108746. https:\/\/doi.org\/10.1016\/j.jsat.2022.108746","journal-title":"Journal of Substance Abuse Treatment"},{"key":"319_CR40","doi-asserted-by":"crossref","unstructured":"Evans, E. A., Pivovarova, E., Senthilkumar, R., Rottapel, R. E., Stopka, T. J., Santelices, C., Ferguson, W. J., Friedmann, P. D. (2023). Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. Int J Drug Policy. 122:104252. PMID: 37980776.","DOI":"10.1016\/j.drugpo.2023.104252"},{"key":"319_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40352-019-0100-2","volume":"7","author":"WJ Ferguson","year":"2019","unstructured":"Ferguson, W. J., Johnston, J., Clarke, J. G., Koutoujian, P. J., Mauer, K., Gallagher, C., White, J., Nickl, D., & Taxman, F. S. (2019). Advancing the implementation and sustainment of medication assisted treatment for opioid use disorder in prisons and jails. Health and Justice, 7, 19. https:\/\/doi.org\/10.1186\/s40352-019-0100-2","journal-title":"Health and Justice"},{"key":"319_CR14","doi-asserted-by":"crossref","unstructured":"Glaser, B., & Strauss, A. (2017). Discovery of grounded theory: Strategies for qualitative research. Routledge.","DOI":"10.4324\/9780203793206"},{"key":"319_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13722-023-00377-y","volume":"18","author":"KA Hoffman","year":"2023","unstructured":"Hoffman, K. A., Thompson, E., Gaeta Gazzola, M., Oberleitner, L. M., Eller, A., Madden, L. M., Marcus, R., Oberleitner, D. E., Beitel, M., & Barry, D. T. (2023). Just fighting for my life to stay alive: A qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories. Addict Sci Clin Pract, 18, 16. https:\/\/doi.org\/10.1186\/s13722-023-00377-y. Published online 2023 Mar 21.","journal-title":"Addict Sci Clin Pract"},{"key":"319_CR27","unstructured":"Massachusetts General Laws. (2018). An Act for Prevention and Access to Appropriate Care and Treatment of Addiction, Chapter 208, Section 98. https:\/\/malegislature.gov\/Laws\/SessionLaws\/Acts\/2018\/Chapter208"},{"key":"319_CR28","unstructured":"Massachusetts Department of Public Health. (2023). Data Brief: Opioid-Related Overdose Deaths among Massachusetts residents. Retrieved from: https:\/\/www.mass.gov\/doc\/opioid-related-overdose-deaths-among-ma-residents-december-2023\/download. Accessed: January 11, 2024."},{"key":"319_CR16","doi-asserted-by":"publisher","first-page":"103823","DOI":"10.1016\/j.drugpo.2022.103823","volume":"109","author":"A Matsumoto","year":"2022","unstructured":"Matsumoto, A., Santelices, C., Evans, E. A., Pivovarova, E., Stopka, T. J., Ferguson, W. J., & Friedmann, P. D. (2022). Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. International Journal of Drug Policy, 109, 103823. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103823","journal-title":"International Journal of Drug Policy"},{"key":"319_CR17","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine. (2019). In A. I. Leshner, & M. Mancher (Eds.), Medications for opioid Use Disorder Save lives (p. 25310). National Academies. https:\/\/doi.org\/10.17226\/25310","DOI":"10.17226\/25310"},{"key":"319_CR29","doi-asserted-by":"publisher","unstructured":"Pivovarova, E., Evans, E. A., Stopka, T. J., Santelices, C., Ferguson, W. J., & Friedmann, P. D. (2022). Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug and Alcohol Dependence, Article 109394. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109394","DOI":"10.1016\/j.drugalcdep.2022.109394"},{"issue":"9","key":"319_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","volume":"108","author":"SI Ranapurwala","year":"2018","unstructured":"Ranapurwala, S. I., Shanahan, M. E., Alexandridis, A. A., Proescholdbell, S. K., Naumann, R. B., Edwards, D. Jr, & Marshall, S. W. (2018). Opioid overdose mortality among former North Carolina inmates: 2000\u20132015. American Journal of Public Health, 108(9), 1207\u20131213. https:\/\/doi.org\/10.2105\/AJPH.2018.304514","journal-title":"American Journal of Public Health"},{"key":"319_CR19","unstructured":"Substance Abuse and Mental Health Services Administration. (SAMHSA, 2022) Recovery and Recovery Support, 2022. Retrieved from: https:\/\/www.samhsa.gov\/find-help\/recovery. Accessed February 14, 2024."},{"key":"319_CR20","doi-asserted-by":"publisher","unstructured":"Schnittker, J., & John, A. (2007). Enduring stigma: the long-term effects of incarceration on health. J Health Soc Behav. ;48(2):115\u201330. https:\/\/doi.org\/10.1177\/002214650704800202. PMID: 17583269.","DOI":"10.1177\/002214650704800202"},{"key":"319_CR21","doi-asserted-by":"publisher","first-page":"103803","DOI":"10.1016\/j.drugpo.2022.103803","volume":"110","author":"TJ Stopka","year":"2022","unstructured":"Stopka, T. J., Rottapel, R. E., Ferguson, W. J., Pivovarova, E., Toro-Mejias, L. D., Friedmann, P. D., & Evans, E. A. (2022). Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. International Journal of Drug Policy, 110, 103803. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103803","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"319_CR22","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s11136-020-02564-9","volume":"30","author":"AM Stover","year":"2021","unstructured":"Stover, A. M., Haverman, L., van Oers, H. A., Greenhalgh, J., Potter, C. M., & ISOQOL PROMs\/PREMs in Clinical Practice Implementation Science Work Group. (2021). Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings. Quality of Life Research, 30(11), 3015\u20133033. https:\/\/doi.org\/10.1007\/s11136-020-02564-9","journal-title":"Quality of Life Research"},{"issue":"6","key":"319_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349\u2013357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"International Journal for Quality in Health Care"},{"key":"319_CR24","unstructured":"U.S. Department of Justice (2022). The Americans with disabilities act and the opioid crisis: Combatting discrimination against people in treatment or recovery. Civil Rights Division. Available at: https:\/\/archive.ada.gov\/opioid_guidance.pdf Last accessed January 17, 2025."},{"issue":"14","key":"319_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJMp1917360","volume":"382","author":"ND Volkow","year":"2020","unstructured":"Volkow, N. D. (2020). Stigma and the toll of addiction. New England Journal of Medicine, 382(14), 1289\u20131290. https:\/\/doi.org\/10.1056\/NEJMp1917360","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"319_CR26","doi-asserted-by":"publisher","first-page":"e180558","DOI":"10.1001\/jamanetworkopen.2018.0558","volume":"1","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman, T. N. A., Chang, V. W., Binswanger, I. A., & Health (2018). Polysubstance Use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Netw Open, 1(3), e180558. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0558","journal-title":"JAMA Netw Open"}],"container-title":["Health &amp; Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-025-00319-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40352-025-00319-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-025-00319-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:30:38Z","timestamp":1745339438000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthandjusticejournal.biomedcentral.com\/articles\/10.1186\/s40352-025-00319-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["319"],"URL":"https:\/\/doi.org\/10.1186\/s40352-025-00319-7","relation":{},"ISSN":["2194-7899"],"issn-type":[{"value":"2194-7899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in accordance with the Declaration of Helsinki. All participants provided verbal informed consent prior to study enrollment. All research procedures were approved by the Baystate Health Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}